Product Information

POTASSIUM CL ER 8 MEQ TABLET is a generic product labeled by Epic Pharma LLC, priced at $0.1020 per EA under NDC 42806042210. Its NADAC has been published 128 times since Mar 13, 2024.

FDA first approved this application on Jun 22, 2018. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 8 MEQ TABLET

Potassium Chloride
$0.1020per EA

Strength

600 mg/1

Manufacturer

Epic Pharma LLC

NDC

42806042210

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209314

FDA Approved

6/22/2018

TE Code

AB2

On Market Since

8/7/2023

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 8 MEQ TABLET has been published 128 times since Mar 13, 2024, and over the history we have for it it has declined 29.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1020 per EA
All-time high$0.1745 (Apr 10, 2024)
All-time low$0.1020 (Aug 19, 2026)
52-week high$0.1413
52-week low$0.1020
Median price$0.1304
Average price$0.1295
Largest weekly change-39.3% (Apr 17, 2024)
Weeks tracked128
Tracking sinceMar 13, 2024

Price History

1W

-6.4%

1M

-6.4%

3M

-17.0%

6M

-20.0%

1Y

-27.8%

3Y

N/A

5Y

N/A

All

-29.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 8 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ TABLET, manufactured by Epic Pharma LLC, is $0.1020 per EA (NDC 42806042210), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 8 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has declined 29.3%. It has been tracked across 128 weekly CMS publications since Mar 13, 2024.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ TABLET?

Since Mar 13, 2024, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has ranged from a low of $0.1020 (Aug 19, 2026) to a high of $0.1745 (Apr 10, 2024), with a median of $0.1304 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 8 MEQ TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 8 MEQ TABLET?

POTASSIUM CL ER 8 MEQ TABLET (NDC 42806042210) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.